76 results on '"Fredersdorf S"'
Search Results
2. Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure
- Author
-
Schneider, H.-J., Husser, O., Rihm, M., Fredersdorf, S., Birner, C., Dhein, S., Muders, F., Jeron, A., Goegelein, H., Riegger, G. A., and Luchner, A.
- Published
- 2009
- Full Text
- View/download PDF
3. Predictors for high ventricular arrhythmia burden in patients with heart failure with reduced ejection fraction and central sleep apnea: an analysis of the SERVE-HF major substudy
- Author
-
Fisser, C, primary, Bureck, J, additional, Gall, L, additional, Vaas, V, additional, Priefert, J, additional, Fredersdorf, S, additional, Zeman, F, additional, Linz, D, additional, Wöhrle, H, additional, Tamisier, R, additional, Teschler, H, additional, Cowie, M, additional, and Arzt, M, additional
- Published
- 2021
- Full Text
- View/download PDF
4. Assessment of the anatomic regurgitant orifice in aortic regurgitation: a clinical magnetic resonance imaging study
- Author
-
Debl, K, Djavidani, B, Buchner, S, Heinicke, N, Fredersdorf, S, Haimerl, J, Poschenrieder, F, Feuerbach, S, Riegger, G A J, and Luchner, A
- Published
- 2008
- Full Text
- View/download PDF
5. P5696The first results from multicentre study of noninvasive epi-endocardial panoramic mapping of ventricular arrhythmias
- Author
-
Chmelevsky, M, primary, Zubarev, S, additional, Budanova, M, additional, Potyagaylo, D, additional, Uecer, E, additional, Parreira, L, additional, Treshkur, T, additional, Fredersdorf, S, additional, Adragao, P, additional, and Lebedev, D, additional
- Published
- 2019
- Full Text
- View/download PDF
6. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers
- Author
-
Fredersdorf, S, Burns, J, Milne, AM, Packham, G, Fallis, L, Gillett, CE, Royds, JA, Peston, D, Hall, PA, Hanby, AM, Barnes, DM, Shousha, S, O'Hare, MJ, and Lu, X
- Subjects
biological phenomena, cell phenomena, and immunity ,neoplasms - Abstract
The expression of cyclin-dependent kinase inhibitor p27(kip1) in human tumors and normal tissues was investigated using a panel of novel anti-p27(kip1) mAbs. An inverse correlation between expression of p27(kip1) and cell proliferation was generally observed after analyzing its expression in 25 different normal human tissues. In some highly proliferative human breast cancer cells, however, high level p27(kip1) expression was seen, indicating the existence of a mechanism by which some growing tumor cells may tolerate this inhibitor of cell cycle progression. Detailed studies demonstrated a correlation between the high level expression of p27(kip1) and cyclin D1 in human breast cancer cells. There was also an inverse correlation between the expression of p27(kip1) and the degree of tumor malignancy in human breast and colorectal cancers, indicating that p27(kip1) may be a useful prognostic marker in these cancers.
- Published
- 2016
7. p27(kip1) localisation is an independent prognostic marker for colorectal cancer
- Author
-
Royds, JA, Stewart, R, Silcocks, PS, Shorthouse, AJ, Santini, A, Fredersdorf, S, and Lu, X
- Published
- 2016
8. A unique access for the ablation catheter to treat electrical storm in a patient with extracorporeal life support
- Author
-
Ucer, E., primary, Fredersdorf, S., additional, Jungbauer, C., additional, Debl, K., additional, Philipp, A., additional, Amann, M., additional, Holzamer, A., additional, Keyser, A., additional, Hilker, M., additional, Luchner, A., additional, Schmid, C., additional, Riegger, G., additional, and Endemann, D., additional
- Published
- 2013
- Full Text
- View/download PDF
9. Lone atrial fibrillation as a positive predictor of left atrial volume reduction following ablation of atrial fibrillation
- Author
-
Fredersdorf, S., primary, Ucer, E., additional, Jungbauer, C., additional, Dornia, C., additional, Eglmeier, J., additional, Eissnert, C., additional, Hamer, O. W., additional, Weber, S., additional, Arzt, M., additional, and von Bary, C., additional
- Published
- 2013
- Full Text
- View/download PDF
10. E2F1 induced apoptosis requires DNA binding but not transcriptional activity and is inhibited by RB
- Author
-
Hsieh, J, Fredersdorf, S, and Lu, X
- Published
- 1997
11. Characterization of a panel of novel anti-p21Waf1/Cip1 monoclonal antibodies and immunochemical analysis of p21Waf1/Cip1 expression in normal human tissues
- Author
-
Fredersdorf, S, Milne, A, Hall, P, and Lu, X
- Subjects
Cyclin-Dependent Kinase Inhibitor p21 ,Osteosarcoma ,Immunochemistry ,Immunoblotting ,Molecular Sequence Data ,Antibodies, Monoclonal ,Precipitin Tests ,Recombinant Proteins ,Gene Expression Regulation ,Reference Values ,Cyclins ,Tumor Cells, Cultured ,Humans ,Amino Acid Sequence ,biological phenomena, cell phenomena, and immunity ,neoplasms ,Research Article - Abstract
As a universal inhibitor of cyclin-dependent kinases and one of the target genes of the tumor suppresser p53, p21Waf1/Cip1 can act as a tumor suppresser through its ability to control cell cycle progression. To study the function of p21Waf1/Cip1 protein and to investigate its tissue distribution, a panel of anti-p21Waf1/Cip1 monoclonal antibodies was generated. These anti-p21Waf1/Cip1 monoclonal antibodies were initially raised against a GST-p21Waf1/Cip1 fusion protein produced in bacteria. Detailed characterization of the antibodies showed that they can specifically detect p21Waf1/Cip1 by immunoblotting, immunoprecipitation, and immunostaining. The specific induction of p21Waf1/Cip1 expression in response to gamma-radiation in cells containing p53 was also detected by these antibodies. The ability to detect p21Waf1/Cip1 expression in conventionally fixed tissue sections allowed us to investigate the distribution of p21Waf1/Cip1 in 23 different types of normal human tissues, and p21Waf1/Cip1 expression was found in most tissues. A close inverse relationship between p21Waf1/Cip1 expression and proliferation was seen in some tissues, including gastrointestinal tract. However, such association is not universal. In tissues such as lung, kidney, thyroid, pancreatic ducts and acini, and liver, despite the fact that most of the cells are quiescent, expression of p21Waf1/Cip1 was detected only in occasional epithelial cells. All these suggest that the expression of p21Waf1/Cip1 varies among different human tissues. Finally, epitope mapping of the anti-p21Waf1/Cip1 antibodies using a peptide library covering the entire p21Waf1/Cip1 protein sequence indicates that two of the antibodies recognize a region of p21Waf1/Cip1 close to that bound by proliferating cell nuclear antigen. These two monoclonal antibodies will therefore be additionally useful in further understanding the functions of p21Waf1/Cip1 both in vitro and in vivo.
- Published
- 1996
12. A variant PDGF incorporated into fibrin sealant for treatment of burn patients undergoing autologous mesh skin grafting
- Author
-
Lehnhardt, M., primary, Hauser, J., additional, Daigeler, A., additional, Fredersdorf, S., additional, Dragieva, G., additional, Ploder, B., additional, Soucek, T., additional, Beuchat, A. Jen, additional, Abrams, S., additional, and Jamieson, V., additional
- Published
- 2009
- Full Text
- View/download PDF
13. Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure
- Author
-
Schneider, H.-J., primary, Husser, O., additional, Rihm, M., additional, Fredersdorf, S., additional, Birner, C., additional, Dhein, S., additional, Muders, F., additional, Jeron, A., additional, Goegelein, H., additional, Riegger, G. A., additional, and Luchner, A., additional
- Published
- 2008
- Full Text
- View/download PDF
14. Erhöhte Gefäßelastizität mesenterialer Widerstandsgefäße bei experimenteller Leberzirrhose
- Author
-
Moleda, L, primary, Resch, M, additional, Fredersdorf, S, additional, Schölmerich, J, additional, Endemann, DH, additional, and Wiest, R, additional
- Published
- 2008
- Full Text
- View/download PDF
15. Increased Aldosterone Levels in a Model of Type 2 Diabetes Mellitus
- Author
-
Fredersdorf, S., primary, Endemann, D., additional, Luchner, A., additional, Heitzmann, D., additional, Ulucan, C., additional, Birner, C., additional, Schmid, P., additional, Stoelcker, B., additional, Resch, M., additional, Muders, F., additional, AJ Riegger, G., additional, and Weil, J., additional
- Published
- 2008
- Full Text
- View/download PDF
16. Erhöhte Gefäßelastizität mesenterialer Widerstandsgefässe bei experimenteller Leberzirrhose
- Author
-
Wiest, R, primary, Moleda, L, additional, Resch, M, additional, Fredersdorf, S, additional, Schoelmerich, J, additional, and Endemann, D, additional
- Published
- 2008
- Full Text
- View/download PDF
17. Erhöhte Gefäßelastizität mesenterialer Widerstandsgefäße bei experimenteller Leberzirrhose
- Author
-
Wiest, R, primary, Resch, M, additional, Fredersdorf, S, additional, Schölmerich, J, additional, and Endemann, D, additional
- Published
- 2007
- Full Text
- View/download PDF
18. Early onset of chondroitin sulfate and osteopontin expression in angiotensin ii-dependent left ventricular hypertrophy1
- Author
-
ROTHERMUND, L, primary, KREUTZ, R, additional, KOSSMEHL, P, additional, FREDERSDORF, S, additional, SHAKIBAEI, M, additional, SCHULZETANZIL, G, additional, PAUL, M, additional, and GRIMM, D, additional
- Published
- 2002
- Full Text
- View/download PDF
19. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.
- Author
-
Hsieh, J K, primary, Fredersdorf, S, additional, Kouzarides, T, additional, Martin, K, additional, and Lu, X, additional
- Published
- 1997
- Full Text
- View/download PDF
20. Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure.
- Author
-
Schneider, H.-J., Husser, O., Rihm, M., Fredersdorf, S., Birner, C., Dhein, S., Muders, F., Jeron, A., Goegelein, H., Riegger, G., and Luchner, A.
- Abstract
Congestive heart failure (CHF) is often associated with atrial fibrillation. The safety of many antiarrhythmic drugs in CHF is limited by proarrhythmic effects. We aimed to assess the safety of a novel atrial-selective K
+ -channel blocker AVE0118 in CHF compared to a selective (dofetilide) and a non-selective IKr blocker (terfenadine). For the induction of CHF, rabbits ( n = 12) underwent rapid right ventricular pacing (330–380 bpm for 30 days). AVE0118 (1 mg/kg) dofetilide (0.02 mg/kg) and terfenadine (2 mg/kg) were administered in baseline (BL) and CHF. A six-lead ECG was continuously recorded digitally for 30 min after each drug administration. At BL, dofetilide and terfenadine significantly prolonged QTc interval (218 ± 30 ms vs 155 ± 8 ms, p = 0.001 and 178 ± 23 ms vs. 153 ± 12 ms, p = 0.01, respectively) while QTc intervals were constant after administration of AVE0118 ( p = n.s.). In CHF, dofetilide and terfenadine caused torsades de pointes and symptomatic bradycardia, respectively, and prolonged QTc interval (178 ± 30 ms vs. 153 ± 14 ms, p = 0.02 and 157 ± 7 ms vs. 147 ± 10 ms, p = 0.02, respectively) even at reduced dosages, whereas no QTc-prolongation or arrhythmia was observed after full-dose administration of AVE0118. In conclusion, atrial-selective K+ -channel blockade by AVE0118 appears safe in experimental CHF. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
21. Alterations in myocardial creatinine kinase (CK) and lactate dehydrogenase (LDH) isoenzyme-distribution in a model of left ventricular dysfunction.
- Author
-
Muders, Frank, Neubauer, Stefan, Luchner, Andreas, Fredersdorf, Sabine, Ickenstein, Guntram, Riegger, Günter A.J., Horn, Michael, Elsner, Dietmar, Muders, F, Neubauer, S, Luchner, A, Fredersdorf, S, Ickenstein, G, Riegger, G A, Horn, M, and Elsner, D
- Subjects
KINASES ,CREATININE ,LACTATE dehydrogenase ,ADRENALINE ,CARDIOMYOPATHIES ,LABORATORY rabbits - Abstract
The purpose of the current study was to evaluate myocardial creatinine kinase (CK) and lactate dehydrogenase (LDH) systems in a model of epinephrine-induced cardiomyopathy in rabbits. Eight rabbits received four repetitive epinephrine infusions (300 mg/kg/60 min, i.v.) in 12-day intervals and eight untreated rabbits served as controls (CTRL). Echocardiography demonstrated a significant deterioration of LV function as well as increased LV-diameter and -mass index in catecholamine-induced cardiomyopathy. Histological examination revealed that repetitive catecholamine infusion resulted in LV fibrous areas with collagenous content and an increase in myocyte width (16.9 ± 0.8 μm vs. CTRL 12.9 ± 0.9; P < 0.05). LV dysfunction was associated with a decreased total LV lactate dehydrogenase activity (LDH; 0.43 ± 0.03 IU/mg protein vs. CTRL 0.52 ± 0.04; P < 0.05) whereas total creatinine kinase activity was unchanged (CK; 7.30 ± 0.63 IU/mg protein vs. CTRL 9.20 ± 0.49, n.s.). Furthermore, myocardial LDH isoenzymes were shifted with a decrease in LDH1 and an increase in LDH2 and LDH3 (LDH1: 84.90 ± 2.60% vs. CTRL 94.50 ± 0.40; LDH2: 7.30 ± 1.20% vs. 1.50 ± 0.13; LDH3: 5.40 ± 0.90% vs. 3.20 ± 0.25; all P < 0.05). Foetal B-CK isoenzymes were significantly increased (CK-MB 5.30 ± 0.66 vs. 2.20 ± 0.35%; P < 0.05). The current study demonstrates changes in cardiac energy metabolism including an impaired LDH activity with a shift towards anaerobic isoenzymes as well as a more efficient CK system in a model of catecholamine-induced LV dysfunction. [ABSTRACT FROM PUBLISHER]
- Published
- 2001
- Full Text
- View/download PDF
22. Effects of growth hormone on renal renin gene expression in normal rats and rats with myocardial infarction.
- Author
-
Kammerl, M C, Grimm, D, Nabel, C, Schweda, F, Bach, M, Fredersdorf, S, Piehler, H, Holmer, S R, Riegger, G A, Kromer, E P, and Krämer, B K
- Abstract
Published data regarding effects of growth hormone (GH) on the renin system are controversial. The aim of this study therefore was to evaluate the effects of GH on the renin system in normal rats and rats with myocardial infarction (MI).
- Published
- 2000
- Full Text
- View/download PDF
23. Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: In vivo and in vitro data
- Author
-
Fredersdorf Sabine, Thumann Christian, Zimmermann Wolfram H, Vetter Roland, Graf Tobias, Luchner Andreas, Riegger Günter AJ, Schunkert Heribert, Eschenhagen Thomas, and Weil Joachim
- Subjects
Diabetic heart ,Insulin ,SERCA expression ,Relaxation velocity ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Background Calcium (Ca2+) handling proteins are known to play a pivotal role in the pathophysiology of cardiomyopathy. However little is known about early changes in the diabetic heart and the impact of insulin treatment (Ins). Methods Zucker Diabetic Fatty rats treated with or without insulin (ZDF ± Ins, n = 13) and lean littermates (controls, n = 7) were sacrificed at the age of 19 weeks. ZDF + Ins (n = 6) were treated with insulin for the last 6 weeks of life. Gene expression of Ca2+ ATPase in the cardiac sarcoplasmatic reticulum (SERCA2a, further abbreviated as SERCA) and phospholamban (PLB) were determined by northern blotting. Ca2+ transport of the sarcoplasmatic reticulum (SR) was assessed by oxalate-facilitated 45Ca-uptake in left ventricular homogenates. In addition, isolated neonatal cardiomyocytes were stimulated in cell culture with insulin, glucose or triiodthyronine (T3, positive control). mRNA expression of SERCA and PLB were measured by Taqman PCR. Furthermore, effects of insulin treatment on force of contraction and relaxation were evaluated by cardiomyocytes grown in a three-dimensional collagen matrix (engineered heart tissue, EHT) stimulated for 5 days by insulin. By western blot phosphorylations status of Akt was determed and the influence of wortmannin. Results SERCA levels increased in both ZDF and ZDF + Ins compared to control (control 100 ± 6.2 vs. ZDF 152 ± 26.6* vs. ZDF + Ins 212 ± 18.5*# % of control, *p Conclusion The current data demonstrate that early type 2 diabetes is associated with an increase in the SERCA/PLB ratio and that insulin directly stimulates SERCA expression and relaxation velocity. These results underline the important role of insulin and calcium handling proteins in the cardiac adaptation process of type 2 diabetes mellitus contributing to cardiac remodeling and show the important role of PI3-kinase-Akt-SERCA2a signaling cascade.
- Published
- 2012
- Full Text
- View/download PDF
24. Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report
- Author
-
Brunner Sabine, Kreuzer Peter, Griese Daniel P, Birner Christoph, Schach Christian, Weil Joachim, Fredersdorf Sabine, Amann Kerstin, Schmid Peter, Resch Markus, Luchner Andreas, Riegger Günter AJ, and Endemann Dierk H
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Background Aldosterone levels are elevated in a rat model of type 2 diabetes mellitus, the Zucker Diabetic fatty rat (ZDF). Moreover blood pressure in ZDF rats is salt-sensitive. The aim of this study was to examine the effect of the aldosterone antagonist eplerenone on structural and mechanical properties of resistance arteries of ZDF-rats on normal and high-salt diet. Methods After the development of diabetes, ZDF animals were fed either a normal salt diet (0.28%) or a high-salt diet (5.5%) starting at an age of 15 weeks. ZDF rats on high-salt diet were randomly assigned to eplerenone (100 mg/kg per day, in food) (ZDF+S+E), hydralazine (25 mg/kg per day) (ZDF+S+H), or no treatment (ZDF+S). Rats on normal salt-diet were assigned to eplerenone (ZDF+E) or no treatment (ZDF). Normoglycemic Zucker lean rats were also divided into two groups receiving normal (ZL) or high-salt diet (ZL+S) serving as controls. Systolic blood pressure was measured by tail cuff method. The experiment was terminated at an age of 25 weeks. Mesenteric resistance arteries were studied on a pressurized myograph. Specifically, vascular hypertrophy (media-to-lumen ratio) and vascular stiffness (strain and stress) were analyzed. After pressurized fixation histological analysis of collagen and elastin content was performed. Results Blood pressure was significantly higher in salt-loaded ZDF compared to ZDF. Eplerenone and hydralazine prevented this rise similarily, however, significance niveau was missed. Media-to-lumen ratio of mesenteric resistance arteries was significantly increased in ZDF+S when compared to ZDF and ZL. Both, eplerenone and hydralazine prevented salt-induced vascular hypertrophy. The strain curve of arteries of salt-loaded ZDF rats was significantly lower when compared to ZL and when compared to ZDF+S+E, but was not different compared to ZDF+S+H. Eplerenone, but not hydralazine shifted the strain-stress curve to the right indicating a vascular wall composition with less resistant components. This indicates increased vascular stiffness in salt-loaded ZDF rats, which could be prevented by eplerenone but not by hydralazine. Collagen content was increased in ZL and ZDF rats on high-salt diet. Eplerenone and hydralazine prevented the increase of collagen content. There was no difference in elastin content. Conclusion Eplerenone and hydralazine prevented increased media-to-lumen ratio in salt-loaded ZDF-rats, indicating a regression of vascular hypertrophy, which is likely mediated by the blood pressure lowering-effect. Eplerenone has additionally the potential to prevent increased vascular stiffness in salt-loaded ZDF-rats. This suggests an effect of the specific aldosterone antagonist on adverse vascular wall remodelling.
- Published
- 2011
- Full Text
- View/download PDF
25. H008: Methotrexate fails to suppress cardiac cytokine induction in pressure overload hypertrophy in rats.
- Author
-
Jeron, A., Fredersdorf, S., Straub, R., Riegger, Günter A.J., and Muders, F.
- Published
- 2000
- Full Text
- View/download PDF
26. A Pilot Trial to Compare the Long-Term Efficacy of Pulmonary Vein Isolation with High-Power Short-Duration Radiofrequency Versus Laser Energy with Rapid Ablation Mode.
- Author
-
Schildt S, Fredersdorf S, Jungbauer CG, Hauck C, Tarnowski D, Debl K, Neef S, Schach C, Sossalla S, Maier LS, and Üçer E
- Abstract
Background: Pulmonary vein (PV) reconnection is the major cause of atrial fibrillation (AF) recurrence after pulmonary vein isolation (PVI). The probability of reconnection is higher if the primary lesion is not sufficiently effective, which can be unmasked with an adenosine provocation test (APT). High-power short-duration radiofrequency energy (HPSD) guided with ablation index (AI) and the third generation of the visually guided laser balloon (VGLB) are new methods for PVI., Methods: A total of 70 participants (35 in each group) who underwent a PVI with either AI-guided HPSD (50 W; AI 500 for the anterior and 400 for the posterior wall, respectively) or VGLB ablation were included in this observational pilot trial. Twenty minutes after each PVI, an APT was performed. The primary endpoint was the event-free survival from AF after three years., Results: A total of 137 (100%) PVs in the HPSD arm and 131 PVs (98.5%) in the VGLB arm were initially successfully isolated ( p = 0.24). The overall procedure duration was similar in both arms (155 ± 39 in HPSD vs. 175 ± 58 min in VGLB, p = 0.191). Fluoroscopy time, left atrial dwelling time and duration from the first to the last ablation were longer in the VGLB arm (23 ± 8 vs. 12 ± 3 min, p < 0.001; 157 (111-185) vs. 134 (104-154) min, p = 0.049; 92(59-108) vs. 72 (43-85) min, p = 0.010). A total of 127 (93%) in the HPSD arm and 126 (95%) PVs in the VGLB arm remained isolated after APT ( p = 0.34). The primary endpoint was met 1107 ± 68 days after ablation in 71% vs. 66% in the VGLB and HPSD arms, respectively ( p = 0.65)., Conclusions: HPSD and VGLB did not differ with respect to long-term outcome of PVI. A large, randomized study should be conducted to compare clinical outcomes with respect to these new ablation techniques.
- Published
- 2023
- Full Text
- View/download PDF
27. Ventricular arrhythmia burden in patients with implantable cardioverter defibrillator and remote patient monitoring during different time intervals of the COVID-19 pandemic.
- Author
-
Hauck C, Schober A, Schober A, Fredersdorf S, Hubauer U, Maier L, Keyser A, Huttelmaier M, Fischer T, Jungbauer C, and Ücer E
- Subjects
- Humans, Pandemics, Communicable Disease Control, Arrhythmias, Cardiac epidemiology, Arrhythmias, Cardiac therapy, Monitoring, Physiologic, Defibrillators, Implantable, COVID-19 epidemiology
- Abstract
Purpose: The current study investigated whether the changes in patient care in times of the COVID-19 pandemic, especially the reduction of in-person visits, would result in a deterioration of the arrhythmic and clinical condition of patients with an implantable cardioverter defibrillator (ICD) and remote patient monitoring., Methods: Data were obtained from a local ICD registry. 140 patients who received ICD implantation at our department and had remote patient monitoring were included. The number of patients with ventricular arrhythmias, appropriate ICD therapy, the number of visits to our outpatient clinic and hospitalization due to acute coronary syndrome, stroke or heart failure were compared during three time intervals of the COVID-19 pandemic (first (LD1) and second (LD2) national lockdown in Germany and the time after the first lockdown (postLD1)) and a time interval 1 year before the pandemic began (preCOV). Each time interval was 49 days long., Results: Patients had significantly fewer visits to our outpatient clinic during LD1 (n = 13), postLD1 (n = 22) and LD2 (n = 23) compared to the time interval before the pandemic (n = 43, each p ≤ 0.05). The number of patients with sustained ventricular arrhythmias, appropriate ICD therapy and clinical events showed no significant difference during the time intervals of the COVID-19 pandemic and the time interval 1 year prior., Conclusions: The lockdown measures necessary to reduce the risk of infection during the COVID-19 pandemic, led to a reduction of in-person patient visits, but did not result in a deterioration of the arrhythmic and clinical condition of ICD patients with remote patient monitoring., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
28. Heart failure with recovered ejection fraction (HFrecEF): A new entity with improved cardiac outcome.
- Author
-
Zeller J, Hubauer U, Schober A, Schober A, Keyser A, Fredersdorf S, Uecer E, Maier LS, and Jungbauer C
- Subjects
- Aged, Female, Germany, Humans, Male, Middle Aged, Primary Prevention, Prognosis, Retrospective Studies, Secondary Prevention, Defibrillators, Implantable, Heart Failure mortality, Heart Failure therapy, Patient Readmission statistics & numerical data, Stroke Volume
- Abstract
Background: Aim of the study was a better characterization of heart failure (HF) with recovered ejection fraction (HFrecEF) and undulating EF (HFuEF) with regard to re-hospitalization due to congestive HF (CHF), adequate electric therapies (AETs) and mortality compared to HF with reduced EF (HFrEF), mid-range EF (HFmrEF) and preserved EF (pEF)., Methods: Retrospective study of 342 participants with an implantable cardioverter defibrillator (ICD) for primary or secondary prevention. Type of HF was classified according to left ventricular EF with 4.7 ± 3.1 investigations for each patient., Results: Re-hospitalization due to CHF was similar in HFrecEF (7 (9.5%)), HFmrEF (2(9.0%)) and pEF (8(12.9%); p = n.s.) and significantly higher in HFrEF (62(38.0%)) and HFuEF (6(28.6%); p < .001 compared to HFrecEF and HFrEF). AETs were significantly lower in HFrecEF (13(17.6%)) compared to HFrEF (57(35.0%)), HFmrEF (7(31.8%)), pEF (18(29.0%)) and HFuEF (6(28.6%); each p < .01 compared to HFrecEF). Mortality was similar in HFrecEF (6(8.1%)) compared to HFuEF (0(0%)), pEF (4(6.5%)) and HFmrEF (2(9.0%), p = n.s.) and significantly lower compared to HFrEF (52(31.9%), p < .001). HFrEF was the strongest predictor for mortality besides age and chronic renal insufficiency according to Cox Regression (each p < .05) opposite to arterial hypertension, diabetes, type of cardiomyopathy and secondary prevention ICD indication (each p = n.s.)., Conclusions: HFrecEF indicates as a new entity of HF with similar prognosis as pEF and HFmrEF with regard to re-hospitalization due to CHF and mortality and even better prognosis with regard to AETs. HFuEF showed similar rates of re-hospitalization due to CHF and AETs compared to HFrEF, but lower rates of mortality., (© 2021 The Authors. Pacing and Clinical Electrophysiology published by Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
29. Ventricular arrhythmia in heart failure patients with reduced ejection fraction and central sleep apnoea.
- Author
-
Fisser C, Bureck J, Gall L, Vaas V, Priefert J, Fredersdorf S, Zeman F, Linz D, Wöhrle H, Tamisier R, Teschler H, Cowie MR, and Arzt M
- Abstract
Cheyne-Stokes respiration (CSR) may trigger ventricular arrhythmia in patients with heart failure with reduced ejection fraction (HFrEF) and central sleep apnoea (CSA). This study determined the prevalence and predictors of a high nocturnal ventricular arrhythmia burden in patients with HFrEF and CSA (with and without CSR) and to evaluate the temporal association between CSR and the ventricular arrhythmia burden. This cross-sectional ancillary analysis included 239 participants from the SERVE-HF major sub-study who had HFrEF and CSA, and nocturnal ECG from polysomnography. CSR was stratified in ≥20% and <20% of total recording time (TRT). High burden of ventricular arrhythmia was defined as >30 premature ventricular complexes (PVCs) per hour of TRT. A sub-analysis was performed to evaluate the temporal association between CSR and ventricular arrhythmias in sleep stage N2. High ventricular arrhythmia burden was observed in 44% of patients. In multivariate logistic regression analysis, male sex, lower systolic blood pressure, non-use of antiarrhythmic medication and CSR ≥20% were significantly associated with PVCs >30·h
-1 (OR 5.49, 95% CI 1.51-19.91, p=0.010; OR 0.98, 95% CI 0.97-1.00, p=0.017; OR 5.02, 95% CI 1.51-19.91, p=0.001; and OR 2.22, 95% CI 1.22-4.05, p=0.009; respectively). PVCs occurred more frequently during sleep phases with versus without CSR (median (interquartile range): 64.6 (24.8-145.7) versus 34.6 (4.8-75.2)·h-1 N2 sleep; p=0.006). Further mechanistic studies and arrhythmia analysis of major randomised trials evaluating the effect of treating CSR on ventricular arrhythmia burden and arrhythmia-related outcomes are warranted to understand how these data match with the results of the parent SERVE-HF study., Competing Interests: Conflict of interest: C. Fisser reports grants from the German Heart Foundation/German Foundation of Heart Research during the conduct of the study. Conflict of interest: J. Bureck has nothing to disclose. Conflict of interest: L. Gall has nothing to disclose. Conflict of interest: V. Vaas reports grants from the German Society of Sleep Medicine outside the submitted work. Conflict of interest: J. Priefert has nothing to disclose. Conflict of interest: S. Fredersdorf has nothing to disclose. Conflict of interest: F. Zeman has nothing to disclose. Conflict of interest: D. Linz reports personal fees from Bayer, LivaNova, ResMed and Respicardia outside the submitted work. Conflict of interest: H. Wöhrle is a former employee of ResMed. Conflict of interest: R. Tamisier reports grants from ResMed and personal fees from Agiradom, outside the submitted work. Conflict of interest: H. Teschler reports grants and personal fees from ResMed outside the submitted work. Conflict of interest: M.R. Cowie reports grants and personal fees from ResMed, personal fees from Respicardia, and grants from Bayer, outside the submitted work. Conflict of interest: M. Arzt reports grants from ResMed during the conduct of the study; and personal fees from ResMed, grants and personal fees from Philips Respironics, personal fees from Boehringer Ingelheim, NRI, Novartis, JAZZ Pharmaceuticals, Inspire and Bresotec, and grants from the Else-Kroehner Fresenius Foundation, outside the submitted work., (Copyright ©The authors 2021.)- Published
- 2021
- Full Text
- View/download PDF
30. Novel Implantable Cardioverter Defibrillator Programming With High Rate Cut-Off, Long Detection Intervals and Multiple Anti-Tachycardia Pacing Reduces Mortality.
- Author
-
Schober AD, Schober AL, Hubauer U, Fredersdorf S, Seegers J, Keyser A, Stadler S, Birner C, Maier L, Jungbauer C, and Ücer E
- Subjects
- Atrial Fibrillation mortality, Electric Countershock, Humans, Kaplan-Meier Estimate, Atrial Fibrillation prevention & control, Cardiac Resynchronization Therapy, Defibrillators, Implantable, Tachycardia, Ventricular therapy
- Abstract
Background: Implantable cardioverter defibrillator (ICD) therapies, even when appropriate, are associated with increased risk. Therapy-reducing strategies have been shown to reduce the mortality rate., Methods and results: In total, 895 patients with ICD and cardiac resynchronization therapy with defibrillation function (CRT-D) were included in the study; of these, 506 (57%) patients undergoing secondary prevention were included. Devices implanted before May 2014 were programmed according to conventional programming (CP), the others according to our novel programming (NP) with high rate cut-off, longer detection intervals and 4-6 anti-tachycardia pacing (ATP) trains in the ventricular tachycardia (VT) zone. Time-to-first-event for mortality, appropriate and inappropriate therapies were analyzed. Follow-up time was 24.0 months (IQR 13.0-24.0 months). There was a significant reduction in mortality rate (11.4% vs. 25.4%, P<0.001) and in the rate of appropriate (18.8% vs. 42.2%, P<0.001) and inappropriate therapies (5.2% vs. 18.0%, P<0.001) with NP according to Kaplan-Meier analyses. In multivariate analysis, NP (hazard ratio [HR]=0.35; P<0.001), chronic kidney disease (HR=1.55), reduced ejection fraction (EF) (HR=1.35), secondary ICD indication (HR=2.35) and age at implantation (HR=1.02) were associated with mortality reduction. NP was also associated with significant reduction in the rate of appropriate and inappropriate therapies. These results were consistent after stratification for primary and secondary prevention., Conclusions: Novel ICD programming reduced mortality and morbidity due to appropriate or inappropriate ICD therapies in secondary as well as in primary ICD indication.
- Published
- 2021
- Full Text
- View/download PDF
31. The low acute effectiveness of a high-power short duration radiofrequency current application technique in pulmonary vein isolation for atrial fibrillation.
- Author
-
Ücer E, Jungbauer C, Hauck C, Kaufmann M, Poschenrieder F, Maier L, and Fredersdorf S
- Subjects
- Adenosine, Humans, Recurrence, Treatment Outcome, Atrial Fibrillation diagnosis, Atrial Fibrillation surgery, Catheter Ablation, Pulmonary Veins surgery
- Abstract
Background: Application of high power radiofrequency (RF) energy for a short duration (HPSD) to isolate pulmonary vein (PV) is an emerging technique. But power and duration settings are very different across different centers. Moreover, despite encouraging preclinical and clinical data, studies measuring acute effectiveness of various HPSD settings are limited., Methods: Twenty-five consecutive patients with symptomatic atrial fibrillation (AF) were treated with pulmonary vein isolation (PVI) using HPSD. PVI was performed with a contact force catheter (Thermocool SF Smart-Touch) and Carto 3 System. The following parameters were used: energy output 50 W, target temperature 43°C, irrigation 15 mL/min, targeted contact force of > 10 g. RF energy was applied for 6-10 s. Required minimal interlesion distance was 4 mm. Twenty minutes after each successful PVI adenosine provocation test (APT) was performed by administrating 18 mg adenosine to unmask dormant PV conduction., Results: All PVs (100 PVs) were successfully isolated. RF lesions needed per patient were 131 ± 41, the average duration for each RF application was 8.1 ± 1.7 s. Procedure time was 138 ± 21 min and average of total RF energy duration was 16.3 ± 5.2 min and average amount of RF energy was 48209 ± 12808 W. APT application time after PVI was 31.1 ± 8.3 min for the left sided PVs and 22.2 ± 4.6 min (p = 0.005) for the right sided PVs. APT was transiently positive in 18 PVs (18%) in 8 (32%) patients., Conclusions: Pulmonary vein isolation with high power for 6-10 s is feasible and shortens the procedure and ablation duration. However, acute effectiveness of the HPSD seems to be lower than expected. Further studies combining other ablation parameters are needed to improve this promising technique.
- Published
- 2021
- Full Text
- View/download PDF
32. High Predictive Value of Adenosine Provocation in Predicting Atrial Fibrillation Recurrence After Pulmonary Vein Isolation With Visually Guided Laser Balloon Compared With Radiofrequency Ablation.
- Author
-
Üçer E, Fredersdorf S, Seegers J, Poschenrieder F, Hauck C, Maier L, and Jungbauer C
- Subjects
- Action Potentials, Aged, Atrial Fibrillation diagnosis, Atrial Fibrillation physiopathology, Electrocardiography, Ambulatory, Female, Germany, Humans, Male, Middle Aged, Predictive Value of Tests, Pulmonary Veins physiopathology, Recurrence, Reoperation, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, Adenosine administration & dosage, Atrial Fibrillation surgery, Catheter Ablation adverse effects, Electrophysiologic Techniques, Cardiac, Heart Rate, Laser Therapy adverse effects, Pulmonary Veins surgery
- Abstract
Background: We recently demonstrated that the acute reconnection rate detected with adenosine provocation test (APT) was significantly lower after pulmonary vein isolation (PVI) with visually guided laser balloon ablation (VGLB) than with RF ablation (RF). We evaluated the recurrence rate of atrial arrhythmias at 12 months after VGLB vs. RF and the significance of APT results for the outcome.Methods and Results:Fifty patients with paroxysmal AF were randomized to either RF or VGLB ablation in a 1 : 1 fashion. After PVI each PV underwent an APT. All patients underwent a 3-day Holter and clinical follow-up every 3 months. Significantly less PVs reconnected during APT in the VGLB-arm (10 PV (10.8%) vs. 29 PV (30.9%); P=0.001). Significantly less patients had a recurrence of atrial arrhythmia in the VGLB-arm (3 vs. 9; P=0.047). In the VGLB-arm no recurrence was seen in those patients with a negative APT (negative predictive value (NPV)=100%). Only 3 of the 8 patients with a positive APT in the VGLB-arm had a recurrence (positive PV (PPV)=37%). Recurrences in the RF-arm were seen in 3 patients with positive APT as well as in 6 patients with negative APT (PPV=18% and NPV=33%)., Conclusions: There was significantly less recurrence of atrial arrhythmias at 12 months after PVI with VGLB. A negative APT after PVI with VGBL predicted freedom from AF with a very high NPV meaning that the high acute efficiency of the VGLB persisted long term.
- Published
- 2020
- Full Text
- View/download PDF
33. Clinical Impact of the Microembolic Signal Burden During Catheter Ablation for Atrial Fibrillation: Just a Lot of Noise?
- Author
-
von Bary C, Deneke T, Arentz T, Schade A, Lehrmann H, Schwab-Malek S, Fredersdorf S, Baldaranov D, Maier L, and Schlachetzki F
- Subjects
- Aged, Atrial Fibrillation complications, Atrial Fibrillation physiopathology, Female, Follow-Up Studies, Humans, Intracranial Embolism complications, Intracranial Embolism physiopathology, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Prospective Studies, Pulmonary Veins diagnostic imaging, Risk Factors, Atrial Fibrillation surgery, Catheter Ablation methods, Intracranial Embolism diagnosis, Pulmonary Veins physiopathology, Signal Processing, Computer-Assisted, Ultrasonography, Doppler, Transcranial methods
- Abstract
Objectives: Microembolic signal detection by transcranial Doppler ultrasonography may be considered a surrogate for cerebral events during invasive cardiac procedures. However, the impact of the microembolic signal count during pulmonary vein isolation on the clinical outcome is not well evaluated. We investigated the effect of the microembolic signal count on the occurrence of new silent cerebral embolism measured by diffusion-weighted imaging (DWI)-magnetic resonance imaging (MRI), changes in neuropsychological testing, and the occurrence of clinical events during long-term follow-up after pulmonary vein isolation., Methods: Pulmonary vein isolation was performed in 41 patients. The total microembolic signal burden (classified into "solid," "gaseous," and "equivocal") and sustained thromboembolic showers of greater than 30 seconds were recorded. Diffusion-weighted imaging-MRI and neuropsychological testing were performed before and after pulmonary vein isolation to assess for silent cerebral embolism and neuropsychological sequelae. Long-term follow-up was performed by telephone to assess for stroke/transient ischemic attack., Results: A total of 68,729 microembolic signals (14,893 solid, 11,909 gaseous, and 41,927 equivocal) with an average of 1676 signals per patient and 42 thromboembolic showers were recorded. No correlation between the microembolic signal/thromboembolic shower count and the occurrence of new DWI lesions or neuropsychological capability was found. After a mean follow-up ± SD of 49 ± 4 months, 1 patient had an overt transient ischemic event, which was not associated with a high microembolic signal count., Conclusions: In this multicenter study, we found no impact of the intraprocedural microembolic symbol/thromboembolic shower count on the occurrence of new DWI lesions, neuropsychological capability, or overt neurologic deficits after pulmonary vein isolation. Thus, not only the microembolic signal count but also procedural/individual factors may contribute to commensurable clinical damage, which may challenge this method as a valid biomarker during pulmonary vein isolation., (© 2017 by the American Institute of Ultrasound in Medicine.)
- Published
- 2018
- Full Text
- View/download PDF
34. A RAndomized Trial to compare the acute reconnection after pulmonary vein ISolation with Laser-BalloON versus radiofrequency Ablation: RATISBONA trial.
- Author
-
Ücer E, Janeczko Y, Seegers J, Fredersdorf S, Friemel S, Poschenrieder F, Maier LS, and Jungbauer CG
- Subjects
- Action Potentials, Adenosine administration & dosage, Aged, Atrial Fibrillation diagnosis, Atrial Fibrillation physiopathology, Cardiac Catheters, Catheter Ablation instrumentation, Electrophysiologic Techniques, Cardiac, Female, Heart Rate, Humans, Laser Therapy instrumentation, Male, Middle Aged, Pulmonary Veins physiopathology, Recurrence, Risk Factors, Time Factors, Treatment Outcome, Atrial Fibrillation surgery, Catheter Ablation adverse effects, Laser Therapy adverse effects, Pulmonary Veins surgery
- Abstract
Introduction: Dormant conduction and acute reconnection in the pulmonary veins (PV) during a PV isolation can be detected by performing an adenosine provocation test (APT). Visually guided laser balloon ablation (VGLB) creates deep transmural lesions, thus causing less acute reconnection. This study compared the acute PV reconnection rate after isolation with VGLB or with RF using an APT., Methods and Results: Patients with paroxysmal AF were randomized to PVI with the VGLB or RF ablation. Each PV underwent an APT at least 20 minutes after successful isolation with injection of 18 mg adenosine. Primary endpoint was the difference between the two ablation methods regarding acute PV reconnection rate detected with APT. A total of 50 patients were randomized into the study (25 VGLB). The basic characteristics and mean procedure time were not different between the two groups. Note that 96% of the 97 targeted PVs in the VGLB group and 98% of the 96 targeted PVs in the RF group could be isolated (P = 0.41). APT was performed at similar times (after 28 minutes in VGLB-arm vs. after 31.5 minutes in RF-arm; P = 0.12). Significantly less PVs were reconnected during APT in the VGLB group than in the RF group (10 PV [10.8%] vs. 29 PV [30.9%]; P = 0.001)., Conclusion: The acute PV reconnection rate is significantly less after PVI with VGBL than with RF. The clinical significance of this apparently better procedural efficiency of the VGBL ablation should be assessed with new randomized studies looking at AF recurrence., (© 2018 Wiley Periodicals, Inc.)
- Published
- 2018
- Full Text
- View/download PDF
35. Long-term outcomes and predictors of recurrence after pulmonary vein isolation with multielectrode ablation catheter in patients with atrial fibrillation.
- Author
-
Fredersdorf S, Fenzl C, Jungbauer C, Weber S, von Bary C, Dietl A, Seegers J, Maier LS, and Ücer E
- Subjects
- Aged, Catheter Ablation adverse effects, Disease-Free Survival, Electrocardiography, Ambulatory, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Recurrence, Risk Factors, Stroke prevention & control, Time Factors, Treatment Outcome, Atrial Fibrillation physiopathology, Atrial Fibrillation surgery, Catheter Ablation methods, Pulmonary Veins surgery
- Abstract
Purpose: Despite various techniques used in atrial fibrillation ablation, recurrence of atrial arrhythmias still constitutes a clinical problem. The aim of this study was to document the long-term outcomes of pulmonary vein isolation with a ring-shaped ablation catheter (PVAC)., Methods: All consecutive patients presenting with paroxysmal or persistent atrial fibrillation (pxAF or perAF, respectively) treated with PVAC (first generation) were enrolled. After standard follow-up during the first year, all patients were contacted for long-term follow-up. In addition to the patient's medical history, 3-day Holter monitoring was performed. Endpoints were atrial fibrillation-related symptoms, ECG documentation of atrial fibrillation or other left atrial arrhythmias and reablation., Results: In total, 125 patients (78% with pxAF) were enrolled. All but two pulmonary veins (0.4% of 485 pulmonary veins) could be successfully isolated. At 12 months, 83% of patients in the pxAF group and 53% of patients in the perAF group were free from symptoms. The mean long-term follow-up was 51 ± 14 months. Regarding long-term efficacy, 56% of patients in the pxAF group and 28% of patients in the perAF group were free from any recurrence at 72 months. Independent predictors of event-free survival were perAF (hazard ratio 2.76, P = 0.001) and the existence of mild valvular disease (hazard ratio 2.69, P = 0.001). No significant complication due to PVAC occurred, especially no ischemic stroke., Conclusion: Long-term follow-up indicated for the first time in such a considerable cohort that pulmonary vein isolation with PVAC is a safe and very efficient method for treating pxAF - despite known microembolism issues. Patients with perAF receive less benefit from PVAC and ablation therapy should be reserved to pxAF. Significantly, even mild valvular disease was an independent predictor of atrial fibrillation recurrence.
- Published
- 2018
- Full Text
- View/download PDF
36. Close-up of a leadless pacemaker 3 days after implantation.
- Author
-
Ücer E, Irrgang P, Fredersdorf S, and Maier L
- Subjects
- Atrial Fibrillation physiopathology, Equipment Design, Fatal Outcome, Humans, Male, Middle Aged, Operative Time, Antifungal Agents adverse effects, Atrial Fibrillation therapy, Candidiasis drug therapy, Pacemaker, Artificial, Surgical Wound Infection drug therapy, Surgical Wound Infection microbiology
- Published
- 2017
- Full Text
- View/download PDF
37. Online Measurement of Microembolic Signal Burden by Transcranial Doppler during Catheter Ablation for Atrial Fibrillation-Results of a Multicenter Trial.
- Author
-
von Bary C, Deneke T, Arentz T, Schade A, Lehrmann H, Fredersdorf S, Baldaranov D, Maier L, and Schlachetzki F
- Abstract
Introduction: Left atrial pulmonary vein isolation (PVI) is an accepted treatment option for patients with symptomatic atrial fibrillation (AF). This procedure can be complicated by stroke or silent cerebral embolism. Online measurement of microembolic signals (MESs) by transcranial Doppler (TCD) may be useful for characterizing thromboembolic burden during PVI. In this prospective multicenter trial, we investigated the burden, characteristics, and composition of MES during left atrial catheter ablation using a variety of catheter technologies., Materials and Methods: PVI was performed in a total of 42 patients using the circular-shaped multielectrode pulmonary vein ablation catheter (PVAC) technology in 23, an irrigated radiofrequency (IRF) in 14, and the cryoballoon (CB) technology in 5 patients. TCD was used to detect the total MES burden and sustained thromboembolic showers (TESs) of >30 s. During TES, the site of ablation within the left atrium was registered. MES composition was classified manually into "solid," "gaseous," or "equivocal" by off-line expert assessment., Results: The total MES burden was higher when using IRF compared to CB (2,336 ± 1,654 vs. 593 ± 231; p = 0.007) and showed a tendency toward a higher burden when using IRF compared to PVAC (2,336 ± 1,654 vs. 1,685 ± 2,255; p = 0.08). TES occurred more often when using PVAC compared to IRF (1.5 ± 2 vs. 0.4 ± 1.3; p = 0.04) and most frequently when ablation was performed close to the left superior pulmonary vein (LSPV). Of the MES, 17.004 (23%) were characterized as definitely solid, 13.204 (18%) as clearly gaseous, and 44.366 (59%) as equivocal., Discussion: We investigated the burden and characteristics of MES during left atrial catheter ablation for AF. All ablation techniques applied in this study generated a relevant number of MES. There was a significant difference in total MES burden using IRF compared to CB and a tendency toward a higher burden using IRF compared to PVAC. The highest TES burden was found in the PVAC group, particularly during ablation close to the LSPV. The composition of thromboembolic particles was balanced. The impact of MES, TES, and composition of thromboembolic particles on neurological outcome needs to be evaluated further. (Clinical Trial Registration: Deutsches Register Klinischer Studien, https://drks-neu.uniklinik-freiburg.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00003465. DRKS00003465.).
- Published
- 2017
- Full Text
- View/download PDF
38. Unmasking the dormant pulmonary vein conduction with adenosine administration after pulmonary vein isolation with laser energy.
- Author
-
Üçer E, Fredersdorf S, Jungbauer CG, Seegers J, Debl K, Riegger G, and Maier LS
- Subjects
- Aged, Atrial Fibrillation surgery, Catheter Ablation methods, Female, Humans, Male, Middle Aged, Treatment Outcome, Adenosine administration & dosage, Anti-Arrhythmia Agents administration & dosage, Atrial Fibrillation drug therapy, Laser Therapy adverse effects, Postoperative Complications, Pulmonary Veins surgery
- Abstract
Aims: The isolation of the pulmonary veins (PVs) is the mainstay of atrial fibrillation (AF) ablation, which with current ablation techniques can be achieved in almost all cases. Reconnection of PVs constitutes the most frequent cause of AF recurrence. Visually guided laser balloon ablation (VGLA) is a novel system with very high rate of persistence of pulmonary vein isolation (PVI) three months after the first procedure shown in preclinical and clinical studies. We aimed to determine the acute efficiency of the laser energy during PVI with the help of adenosine provocation., Methods and Results: Twenty-six patients (19 male; mean age 64 ± 9 years) with symptomatic paroxysmal AF were included in the study. Pulmonary vein isolation was performed using the VGLA system. After successful PVI, we studied the effects of intravenous adenosine (18 mg) on activation of each PV at least 20 min after PVI. A total of 104 PVs were targeted. The balloon catheter could not be placed in two PVs. Of the remaining 102 PVs 99 (97% of the ablated PVs) could be successfully isolated. Adenosine was administered for each isolated PV in 25 patients. Only six PVs (6.7%) in five patients (20%) showed a PV reconnection during adenosine provocation., Conclusion: Pulmonary vein isolation with VGLA is a feasible technique for PVI with a very effective acute lesion formation. The clinical significance of this low reconnection rate has to be determined., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2015. For permissions please email: journals.permissions@oup.com.)
- Published
- 2015
- Full Text
- View/download PDF
39. Silent cerebral events as a result of left atrial catheter ablation do not cause neuropsychological sequelae--a MRI-controlled multicenter study.
- Author
-
von Bary C, Deneke T, Arentz T, Schade A, Lehrmann H, Eissnert C, Schwab-Malek S, Fredersdorf S, Ücer E, Baldaranov D, Wendl C, and Schlachetzki F
- Subjects
- Asymptomatic Diseases, Atrial Fibrillation complications, Female, Germany, Heart Atria surgery, Heart Conduction System surgery, Humans, Magnetic Resonance Imaging methods, Male, Mental Disorders diagnosis, Neuropsychological Tests, Treatment Outcome, Atrial Fibrillation surgery, Catheter Ablation adverse effects, Intracranial Embolism etiology, Intracranial Embolism pathology, Mental Disorders etiology, Pulmonary Veins surgery
- Abstract
Purpose: Recently, diffusion-weighted magnetic resonance imaging (DW-MRI) revealed silent cerebral events (SCEs) as an acute complication of pulmonary vein isolation (PVI). We investigated whether SCEs following PVI are associated with neuropsychological deficits observed during patients' follow-up examinations., Methods: After PVI, 52 patients were eligible for follow-up. PVI was performed using a variety of ablation technologies (duty-cycled phased radiofrequency (RF) multipolar ablation with the Pulmonary Vein Ablation Catheter® (PVAC) in 24 patients, cooled-tip RF ablation in 23 patients, and cryoballoon ablation in five patients). Fluid-attenuated inversion recovery (FLAIR)- and DW-MRI studies were performed 1 day before PVI and 1 day and 1 month afterward to detect pre-existing cerebral lesions or post-ablation SCEs. At the same times, eight neuropsychological tests were administered. We evaluated changes in patients' neuropsychological capabilities and compared changes in patients with SCEs to those without SCEs., Results: FLAIR-MRI revealed pre-existing cerebral lesions in 42 patients (81 %), and DW-MRI demonstrated new SCEs in 25 patients (48 %) (17 treated with phased RF (PVAC) (71 %), six treated with irrigated RF (26 %), and two treated with cryoablation (40 %)). Neuropsychological test results showed no significant impairment (in median z scores) 1 day and 1 month after the ablation procedure. There was no difference in neuropsychological capabilities between patients with SCEs and those without SCEs except in one subtest (part of the verbal working memory test)., Conclusions: The incidence of pre-existing cerebral lesions and post-ablation SCEs was high. The frequency of SCEs depends on the ablation technology used. Neither PVI nor post-ablation SCEs have any effect on neuropsychological capabilities.
- Published
- 2015
- Full Text
- View/download PDF
40. A unique access for the ablation catheter to treat electrical storm in a patient with extracorporeal life support.
- Author
-
Ücer E, Fredersdorf S, Jungbauer C, Debl K, Philipp A, Amann M, Holzamer A, Keyser A, Hilker M, Luchner A, Schmid C, Riegger G, and Endemann D
- Subjects
- Aged, Coronary Occlusion complications, Coronary Occlusion diagnosis, Coronary Occlusion physiopathology, Equipment Design, Hemodynamics, Humans, Male, Myocardial Infarction diagnosis, Myocardial Infarction etiology, Myocardial Infarction physiopathology, Shock, Cardiogenic diagnosis, Shock, Cardiogenic etiology, Shock, Cardiogenic physiopathology, Treatment Outcome, Ventricular Fibrillation diagnosis, Ventricular Fibrillation etiology, Ventricular Fibrillation physiopathology, Cardiac Catheterization instrumentation, Cardiac Catheters, Catheter Ablation instrumentation, Coronary Occlusion therapy, Extracorporeal Membrane Oxygenation, Myocardial Infarction therapy, Shock, Cardiogenic therapy, Ventricular Fibrillation surgery
- Abstract
Aims: Extracorporeal membrane oxygenation (ECMO) is a very effective bridging therapy in patients with cardiogenic shock. To perform coronary angiography in these patients our group developed an unique system to get urgent vascular access with minimal additional vascular complication risk. The 6 Fr coronary catheters are introduced through a standard Y-connector, which is inserted into the arterial cannula of the ECMO-line close to the patient, the blind end of which is then equipped with a haemostatic valve (Check-Flo Performer accessory adapter, Cook Medical, USA). To the best of our knowledge, we here present the first patient, in whom this system had been used to insert an 8 Fr radiofrequency ablation catheter to treat incessant ventricular fibrillation., Methods and Results: A 66-year-old patient had been transferred with electrical storm 5 days after an acute MI. After failed interventional and medical therapies an ECMO system had been inserted (right femoral artery cannula 15 Fr, left femoral vein cannula 21 Fr) and an electrophysiological study had been performed because of incessant ventricular fibrillation episodes, which always were induced by the same ventricular premature beat (VPB). During this first EP study over the left femoral artery the VPB could be targeted and successfully ablated. Unfortunately the VPB recovered again after some days so a second EP study had to be performed. This time the left femoral artery could not be used because of a postinterventional complication so we used the arterial cannula of the ECMO system as the access for the ablation catheter using a Y-connector. Using this way again a successful ablation procedure could be performed, after getting familiar with manipulation the ablation catheter over the ECMO cannula and with the help of different curved ablation catheters. The issue of compromising of the effective lumen of the arterial cannula by the ablation catheter`s cross sectional area could be overcome with increasing the rotational speed of the V-A ECMO., Conclusion: Ablation of ventricular arrhythmias using a Y-connector to insert the ablation catheter into the arterial cannula is feasible in patients with a V-A ECMO system avoiding additional arterial puncture with potentially major vascular complications in critically ill patients. Manipulation of the catheter is not as easy as using a standard sheath but can well be performed after a short habituation.
- Published
- 2014
- Full Text
- View/download PDF
41. Lone atrial fibrillation as a positive predictor of left atrial volume reduction following ablation of atrial fibrillation.
- Author
-
Fredersdorf S, Ucer E, Jungbauer C, Dornia C, Eglmeier J, Eissnert C, Hamer OW, Weber S, Arzt M, and von Bary C
- Subjects
- Atrial Fibrillation diagnosis, Electrocardiography, Ambulatory, Female, Humans, Male, Middle Aged, Organ Size, Prognosis, Recurrence, Reproducibility of Results, Retrospective Studies, Sensitivity and Specificity, Treatment Outcome, Atrial Fibrillation pathology, Atrial Fibrillation surgery, Catheter Ablation, Heart Atria pathology, Heart Atria surgery
- Abstract
Aims: We investigated predictors of left atrial volume reduction (LAVR) in patients with atrial fibrillation (AF) undergoing AF ablation., Methods and Results: Sixty patients with AF underwent pulmonary vein isolation (PVI) using a pulmonary vein ablation catheter (PVAC). All patients underwent cardiac imaging by computed tomography or magnetic resonance imaging to determine LAV 1 day before and 140 ± 9.5 days after PVI. Clinical follow-up and 72 h electrocardiogram Holter monitoring were performed 1, 3, and 6 months after ablation, and every 6 months thereafter. Significant LAVR (n = 60, 89.3 ± 3.9 vs. 79.5 ± 3.6 mL, P < 0.0001) was shown for the study group as a whole, caused particularly by the subgroup of patients with ablation success (n = 45, 85.2 ± 4.6 vs. 72.5 ± 3.7 mL, P < 0.0001). In addition, significant LAVR was shown for patients with lone AF (n = 25, 88.8 ± 6.8 vs. 72.7 ± 5.3 mL, P < 0.0001), but not for patients with AF and concomitant arterial hypertension (n = 32, 89 ± 4.8 vs. 86.7 ± 5 mL, P = 0.3), coronary artery disease (n = 12, 91.6 ± 7.8 vs. 89.1 ± 7.8 mL, P = 0.26), or left ventricular hypertrophy (n = 10, 86.3 ± 5.5 vs. 83.1 ± 5.3 mL, P = 0.27). Multivariate analysis revealed absence of arterial hypertension, lone AF, ablation success, and initial LA enlargement as independent predictors for significant LAVR following ablation (each P < 0.05)., Conclusion: Based on the subgroup of patients with lone AF, PVI leads to a significant LAVR 4 months after the procedure, especially in patients with clinical success in terms of AF freedom. Comorbidities such as arterial hypertension may prevent this reverse atrial remodelling, despite AF freedom. Clinical implications need to be further elucidated.
- Published
- 2014
- Full Text
- View/download PDF
42. Differential expression of potassium channels and abnormal conduction in experimental tachycardia-induced heart failure.
- Author
-
Birner C, Husser O, Jeron A, Rihm M, Fredersdorf S, Resch M, Schmid P, Endemann D, Riegger G, and Luchner A
- Subjects
- Animals, Heart Atria pathology, Heart Atria physiopathology, Heart Failure genetics, Heart Failure pathology, Heart Ventricles pathology, Heart Ventricles physiopathology, Organ Size, Protein Subunits physiology, Rabbits, Tachycardia genetics, Tachycardia pathology, Gene Expression Regulation, Heart Failure physiopathology, Potassium Channels, Voltage-Gated physiology, Tachycardia physiopathology
- Abstract
Heart failure causes electrophysiological changes in the heart. Downregulation of repolarizing K+-currents leads to a prolongation of the cardiac action potential. Nevertheless, little is known about the differential expression of atrial and ventricular K+-channels in the failing heart. Ten rabbits underwent progressive rapid right ventricular pacing for 30 days. Digitized ECGs and echocardiograms were obtained. Left ventricular and left atrial tissue was harvested and mRNA levels of BNP, Kv4.3, rERG, Kv1.5, and KvLQT1 were measured by real time PCR. Experimental heart failure was characterized by left ventricular dilatation (13 ± 1 mm vs. 9 ± 1, p < .001), depressed fractional shortening (25 ± 5% vs. 40 ± 4, p < .001), and left atrial remodeling with increased diameter (16 mm ± 2 vs. 12 ± 1, p = .002) and weight (1.3 g ± 0.2 vs. 0.5 ± 0.1, p = .01). A prolongation of P-wave (44 ± 5 ms vs. 40 ± 4, p = .001) and PQ-interval (73 ± 10 ms vs. 66 ± 9, p = .009) occurred. In heart failure, BNP mRNA levels showed a significant upregulation in the left ventricle and atrium (1.83 AU ±1.31 vs. 0.67 ± 0.65, p < .05 and 7.16 AU ±1.76 vs. 0.77 ± 0.48, p < .05). Left ventricular Kv1.5 mRNA was reduced by 50% (p < .001) and KvLQT1 was reduced by 70% (p < .001). rERG and Kv4.3 mRNA were unchanged (n = ns). In contrast, left atrial Kv4.3 and KvLQT1 were reduced by 70% (p < .001), whereas rERG and Kv1.5 were unchanged (p = ns). Significant correlations were present between BNP and K+-channel expressions. Heart failure is characterized by significant changes in the gene expression of repolarizing K+-currents with a differential atrial and ventricular pattern. These molecular changes occur together with changes in cardiac function, geometry, conduction, and BNP expression and provide a functional basis for electrical vulnerability in heart failure.
- Published
- 2012
- Full Text
- View/download PDF
43. Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report.
- Author
-
Resch M, Schmid P, Amann K, Fredersdorf S, Weil J, Schach C, Birner C, Griese DP, Kreuzer P, Brunner S, Luchner A, Riegger GA, and Endemann DH
- Subjects
- Animals, Diabetes Mellitus, Type 2 pathology, Diabetes Mellitus, Type 2 physiopathology, Eplerenone, Male, Rats, Rats, Zucker, Spironolactone pharmacology, Spironolactone therapeutic use, Vascular Resistance drug effects, Vascular Resistance physiology, Diabetes Mellitus, Type 2 drug therapy, Sodium Chloride, Dietary adverse effects, Spironolactone analogs & derivatives, Vascular Stiffness drug effects, Vascular Stiffness physiology
- Abstract
Background: Aldosterone levels are elevated in a rat model of type 2 diabetes mellitus, the Zucker Diabetic fatty rat (ZDF). Moreover blood pressure in ZDF rats is salt-sensitive. The aim of this study was to examine the effect of the aldosterone antagonist eplerenone on structural and mechanical properties of resistance arteries of ZDF-rats on normal and high-salt diet., Methods: After the development of diabetes, ZDF animals were fed either a normal salt diet (0.28%) or a high-salt diet (5.5%) starting at an age of 15 weeks. ZDF rats on high-salt diet were randomly assigned to eplerenone (100 mg/kg per day, in food) (ZDF+S+E), hydralazine (25 mg/kg per day) (ZDF+S+H), or no treatment (ZDF+S). Rats on normal salt-diet were assigned to eplerenone (ZDF+E) or no treatment (ZDF). Normoglycemic Zucker lean rats were also divided into two groups receiving normal (ZL) or high-salt diet (ZL+S) serving as controls. Systolic blood pressure was measured by tail cuff method. The experiment was terminated at an age of 25 weeks. Mesenteric resistance arteries were studied on a pressurized myograph. Specifically, vascular hypertrophy (media-to-lumen ratio) and vascular stiffness (strain and stress) were analyzed. After pressurized fixation histological analysis of collagen and elastin content was performed., Results: Blood pressure was significantly higher in salt-loaded ZDF compared to ZDF. Eplerenone and hydralazine prevented this rise similarily, however, significance niveau was missed. Media-to-lumen ratio of mesenteric resistance arteries was significantly increased in ZDF+S when compared to ZDF and ZL. Both, eplerenone and hydralazine prevented salt-induced vascular hypertrophy. The strain curve of arteries of salt-loaded ZDF rats was significantly lower when compared to ZL and when compared to ZDF+S+E, but was not different compared to ZDF+S+H. Eplerenone, but not hydralazine shifted the strain-stress curve to the right indicating a vascular wall composition with less resistant components. This indicates increased vascular stiffness in salt-loaded ZDF rats, which could be prevented by eplerenone but not by hydralazine. Collagen content was increased in ZL and ZDF rats on high-salt diet. Eplerenone and hydralazine prevented the increase of collagen content. There was no difference in elastin content., Conclusion: Eplerenone and hydralazine prevented increased media-to-lumen ratio in salt-loaded ZDF-rats, indicating a regression of vascular hypertrophy, which is likely mediated by the blood pressure lowering-effect. Eplerenone has additionally the potential to prevent increased vascular stiffness in salt-loaded ZDF-rats. This suggests an effect of the specific aldosterone antagonist on adverse vascular wall remodelling.
- Published
- 2011
- Full Text
- View/download PDF
44. Evaluation of pulmonary vein stenosis after pulmonary vein isolation using a novel circular mapping and ablation catheter (PVAC).
- Author
-
von Bary C, Weber S, Dornia C, Eissnert C, Fellner C, Latzin P, Fredersdorf S, Stadler S, and Hamer OW
- Subjects
- Aged, Angiography, Constriction, Pathologic epidemiology, Constriction, Pathologic etiology, Constriction, Pathologic pathology, Female, Humans, Incidence, Magnetic Resonance Imaging, Male, Middle Aged, Pulmonary Veins diagnostic imaging, Risk Factors, Severity of Illness Index, Tomography, Spiral Computed, Vascular Diseases diagnosis, Atrial Fibrillation surgery, Cardiac Imaging Techniques methods, Catheter Ablation adverse effects, Pulmonary Veins pathology, Vascular Diseases epidemiology, Vascular Diseases etiology
- Abstract
Background: Pulmonary vein stenosis (PVST) is a well-known complication of pulmonary vein isolation (PVI). Specific anatomically designed ablation catheters for antral PVI have not been evaluated with regard to the incidence of PVST. We investigated the incidence, severity, and characteristics of PVST after PVI with the Pulmonary Vein Ablation Catheter (PVAC) and phased radiofrequency technology., Methods and Results: A total of 100 patients (55 men) underwent PVI for atrial fibrillation using the PVAC. PVI was guided by selective angiography of each pulmonary vein (PV) in 70 (70%) patients and by reconstructed 3D atriography (ATG) in 30 (30%) patients. Gadolinium-enhanced MRI or multidetector CT was performed in all patients before treatment and 93±78 days after PVI. PVST was classified as follows: insignificant (<25%), mild (25%-50%), moderate (50%-75%), or severe (>75%). A total of 410 PVs were analyzed. Cardiac imaging demonstrated a detectable narrowing of the PV diameter in 23 (23%) patients and in 28 (7%) PVs. In detail, insignificant PVST was observed in 12 (2.9%) PVs, mild PVST in 15 (3.7%), and moderate PVST in 1 (0.2%). No instances of severe PVST were observed. The use of 3D-ATG was associated with a lower incidence of PVST (0.8% [95% CI, 0.0%-2.2%] versus 5.4% [95% CI, 2.7%-8.1%], P=0.027)., Conclusions: To our knowledge, this study is the first to report the incidence of PVST using the PVAC. In this regard, the PVAC seems to be safe if used in an experienced center. In addition, the use of 3D-ATG may decrease the risk of PVST.
- Published
- 2011
- Full Text
- View/download PDF
45. Reversible complete heart block in ANCA-associated vasculitis.
- Author
-
Reinhard W, Kallmuenzer B, Bergua A, Fleck M, Luchner A, Riegger G, and Fredersdorf S
- Subjects
- Adult, Diagnosis, Differential, Female, Humans, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis complications, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis diagnosis, Electrocardiography methods, Heart Block diagnosis, Heart Block etiology
- Published
- 2011
- Full Text
- View/download PDF
46. Hyperaldosteronism and altered expression of an SGK1-dependent sodium transporter in ZDF rats leads to salt dependence of blood pressure.
- Author
-
Resch M, Bergler T, Fredersdorf S, Griese DP, Weil J, Kreuzer P, Brunner S, Riegger GA, Luchner A, and Endemann DH
- Subjects
- Aldosterone metabolism, Animals, Blood Pressure physiology, Disease Models, Animal, Hyperaldosteronism metabolism, Kidney metabolism, Male, Mesenteric Arteries drug effects, Mesenteric Arteries physiopathology, Rats, Rats, Zucker, Sodium metabolism, Vascular Resistance drug effects, Vascular Resistance physiology, Blood Pressure drug effects, Diabetes Mellitus, Type 2 metabolism, Diabetes Mellitus, Type 2 physiopathology, Epithelial Sodium Channels metabolism, Hyperaldosteronism physiopathology, Immediate-Early Proteins metabolism, Protein Serine-Threonine Kinases metabolism, Sodium Chloride, Dietary pharmacology
- Abstract
This study was designed to test whether altered aldosterone-related sodium handling leads to salt-sensitive blood pressure in diabetes and thus may exaggerate end-organ damage. Zucker diabetic fatty (ZDF) rats, a model of type 2 diabetes, and Zucker lean (ZL) rats, as euglycemic controls, were divided into groups receiving normal (0.28%) (ZDF+N, ZL+N) and high-salt (5.5%) diets (ZDF+S, ZL+S) for 10 weeks. Renal mRNA expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) and sodium transporters (for example, the epithelial sodium channel-α, ENaCα) were measured by quantitative reverse transcriptase-PCR. Vascular hypertrophy (media-to-lumen ratio, M/L) in mesenteric resistance arteries was assessed using a pressurized myograph. Systolic blood pressure (SBP) was significantly higher in ZDF+S vs. ZDF+N (146 ± 2 vs. 133 ± 3 mm Hg; P<0.05), whereas there was no difference between ZL+S and ZL+N (151 ± 3 vs. 147 ± 3 mm Hg). Plasma sodium concentration was higher in ZDF+S vs. ZDF+N, whereas there was no difference between ZL+S and ZL+N. Plasma aldosterone concentration (PAC) was higher in ZDF+N as compared with ZL+N (191 ± 23 vs. 95 ± 35 pg ml(-1); P<0.05). PAC decreased to zero in ZL+S, which was not the case in ZDF+S (0 ± 0 vs. 37 ± 2 pg ml(-1)). Salt loading decreased the mRNA expression of SGK1 in euglycemic controls (ZL+S 0.58 ± 0.2 vs. ZL+N 1.05 ± 0.05; P=0.05), whereas it significantly increased SGK1 expression in diabetic rats (ZDF+S 1.75 ± 0.15 vs. ZDF+N 0.92 ± 0.07; P<0.01). ENaCα mRNA expression paralleled these changes. The M/L of mesenteric resistance arteries was not different between ZDF+N and ZL+N. High salt significantly increased the M/L in ZDF+S vs. ZDF+N, but not in ZL+S vs. ZL+N. Systolic blood pressure in this model of type 2 diabetes mellitus is salt sensitive, leading to marked vascular remodeling. The underlying pathophysiological mechanism may be inappropriately high levels of aldosterone and up-regulation of SGK1-dependent renal sodium transport by ENaCα, leading to net increased sodium retention.
- Published
- 2010
- Full Text
- View/download PDF
47. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
- Author
-
Buchner S, Debl K, Barlage S, Griese D, Fredersdorf S, Jeron A, Lubnow M, Müller T, Muders F, Holmer S, Riegger GA, and Luchner A
- Subjects
- Acute Coronary Syndrome blood, Adult, Aged, Biomarkers blood, Coronary Angiography, Coronary Artery Disease blood, Coronary Artery Disease therapy, Data Interpretation, Statistical, Female, Humans, Male, Middle Aged, Myocardial Infarction blood, Myocardial Infarction therapy, Myocardial Reperfusion, Prognosis, Time Factors, Acute Coronary Syndrome therapy, Angioplasty, Balloon, Coronary methods, Natriuretic Peptide, Brain blood, Peptide Fragments blood
- Abstract
Background: Whereas N-terminal pro-brain natriuretic peptide (NT-proBNP) is approved for risk stratification of patients with acute coronary syndromes (ACS), short-term temporal changes in NT-proBNP concentrations and the optimal time points for sampling are not clear. The purpose of this study was to better define the short-term changes in NT-proBNP in relation to clinical presentation, reperfusion and prognostic value in patients with ACS, as well as to identify the optimum time points for sampling., Methods: We studied daily plasma concentrations of NT-proBNP in 133 unselected patients with myocardial infarction (n=65), stable coronary artery disease (CAD, n=46) and no CAD (n=22) who underwent coronary angiography., Results: Patients with non-ST-elevation myocardial infarction (NSTEMI) presented with markedly higher NT-proBNP than patients with ST-elevation myocardial infarction (STEMI) [1305 (741-3208) ng/L vs. 170 (70-424) ng/L, p<0.001]. Also, time to presentation from onset of pain was much longer in NSTEMI as compared to STEMI (>48 h vs. <6 h, p<0.001). Patients with NSTEMI also presented with higher NT-proBNP as compared with CAD [224 (98-732) ng/L] and no CAD [47 (26-102) ng/L; p<0.001, NSTEMI vs. both]. Following successful percutaneous coronary intervention [thrombolysis in myocardial infarction (TIMI) 3-flow established], NT-proBNP increased markedly within 24 h in patients with STEMI [718 (379-1338) ng/L, p<0.01 vs. 0 h], whereas no change in NT-proBNP was noted in patients with NSTEMI [1190 (1010-2024) ng/L, p=0.88 vs. 0 h]. In both STEMI and NSTEMI, NT-proBNP decreased significantly 96 h after successful reperfusion [STEMI -52%, 372 (189-610) ng/L, p<0.05; NSTEMI -52%, 613 (365-724) ng/L, p<0.05]. Unsuccessful reperfusion (TIMI<3) was associated with unchanged or increased NT-proBNP. NT-proBNP at 96 h and peak NT-proBNP further displayed a strong correlation with cardiac troponin T (r=0.64 and r=0.54, p<0.001), a marker of infarct size, and NT-proBNP at 96 h was a strong predictor of long-term prognosis (hazard ratio 7.29, p=0.025)., Conclusions: In patients with NSTEMI, NT-proBNP may be increased as high as concentrations usually associated with acute congestive heart failure despite the absence of clinical signs. In contrast, patients with STEMI and short time to presentation may present with completely normal NT-proBNP, but dramatic short-term increases following reperfusion. NT-proBNP reflects ischemic burden, reperfusion success and prognosis, and the current data support repetitive sampling in patients with ACS.
- Published
- 2010
- Full Text
- View/download PDF
48. First-in-man (FIM) experience with the Magnetic Medical Positioning System (MPS) for intracoronary navigation.
- Author
-
Jeron A, Fredersdorf S, Debl K, Oren E, Izmirli A, Peleg A, Nekovar A, Herscovici A, Riegger GA, and Luchner A
- Subjects
- Aged, Contrast Media, Coronary Stenosis therapy, Coronary Vessels diagnostic imaging, Equipment Design, Feasibility Studies, Female, Germany, Humans, Imaging, Three-Dimensional, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Radiographic Image Interpretation, Computer-Assisted, Ultrasonography, Interventional, Cardiac Catheterization, Cineangiography, Coronary Angiography, Coronary Stenosis diagnostic imaging, Coronary Vessels pathology, Magnetics instrumentation
- Abstract
Aims: To investigate the safety and feasibility of a newly developed magnetic navigation system for intracoronary tracking., Methods and Results: The MediGuide Medical Positioning System (MPS) is a navigation system that was developed to facilitate the navigation of enabled devices within the coronary tree using a magnetic tracking technology. The current prospective, non-randomised, single-centre, first-in-man study was conducted at Universitätsklinikum Regensburg (UKR), Germany on an MPS-enabled AXIOM Artis dFC coronary angiography system (Siemens AG, Forchheim, Germany). We enrolled 20 patients who required IVUS assessment or treatment of a single de novo target lesion in a native coronary artery. The performance was evaluated on a semi-quantitative one-to-five scale where a score of five indicates an excellent superimposition with the vessel and a score of one an unacceptable performance. The mean score for tracking as assessed by projection on life fluoroscopy was 4.89 and 3.58 as assessed by projection on recorded cine-loop. Length measurement of a 20 mm distance was significantly better with the MPS (mean deviation of 0.6 mm=3%) as compared to standard QCA (1.5 mm=8%, p<0.05). Creating a 3D reconstruction was possible in 13 out of 20 cases with an average score of 4.68. No adverse events occurred., Conclusions: The MediGuide Medical Positioning System is safe and feasible in man, facilitates intracoronary navigation and allows 3D reconstruction of the investigated coronary segment.
- Published
- 2009
- Full Text
- View/download PDF
49. Alterations in mechanical properties of mesenteric resistance arteries in experimental portal hypertension.
- Author
-
Resch M, Wiest R, Moleda L, Fredersdorf S, Stoelcker B, Schroeder JA, Schölmerich J, and Endemann DH
- Subjects
- Animals, Biomechanical Phenomena, Blood Pressure, Carbon Tetrachloride, Elasticity, Hypertension, Portal etiology, Hypertension, Portal pathology, Hypertrophy, Ligation, Liver Cirrhosis, Experimental chemically induced, Liver Cirrhosis, Experimental pathology, Male, Mesenteric Arteries ultrastructure, Microscopy, Electron, Myography, Portal Vein surgery, Rats, Rats, Sprague-Dawley, Stress, Mechanical, Vasodilation, Hypertension, Portal physiopathology, Liver Cirrhosis, Experimental physiopathology, Mesenteric Arteries physiopathology, Portal Vein physiopathology, Splanchnic Circulation, Vascular Resistance
- Abstract
Splanchnic vasodilation is the pathophysiological hallmark in the development of the hyperdynamic circulatory syndrome in liver cirrhosis and portal hypertension. This has been attributed so far mainly to a marked vascular hyporeactivity to endogenous vasoconstrictors. However, myogenic tone and vessel stiffness have not been addressed in mesenteric arteries in liver cirrhosis. CCl(4)(-)-induced ascitic cirrhotic (LC) and age-matched control rats, portal vein-ligated (PVL) rats, and sham-operated rats were investigated. Third-order mesenteric resistance arteries were studied under no-flow conditions using a pressure myograph measuring media thickness and lumen diameter in response to incremental increases in intramural pressure, from which wall mechanics were calculated. Electron microscopy was used for investigation of wall ultrastructure, especially the fenestrae in internal elastic lamina (IEL). In PVL animals, no significant change in passive vessel strain, stress, media-to-lumen ratio, or cross-sectional area was noted. In contrast, in LC rats, vessel strain was markedly elevated compared with healthy control rats, indicating a marked reduction in vessel stiffness. In addition, the strain-stress curve was shifted to the right, and the elastic modulus in dependency on vessel stress decreased, demonstrating predominantly structure-dependent factors to be involved. The media-to-lumen quotient was not significantly altered, but cross-sectional area was highly increased in LC rats, indicating hypertrophic outward remodeling. These findings were paralleled by enlarged fenestrae in the IEL but no change in thickness of IEL or proportion of extracellular matrix or vascular smooth muscle in LC rats. We concluded that, in long-standing severe portal hypertension such as ascitic LC but not in short-term conditions such as PVL, mesenteric resistance arteries exhibit vascular remodeling and markedly less resistant mechanical properties, leading to decreased vessel stiffness accompanied by structural changes in the IEL. This may well contribute to the maintenance and severity of splanchnic arterial vasodilation in LC.
- Published
- 2009
- Full Text
- View/download PDF
50. Safe and rapid isolation of pulmonary veins using a novel circular ablation catheter and duty-cycled RF generator.
- Author
-
Fredersdorf S, Weber S, Jilek C, Heinicke N, VON Bary C, Jungbauer C, Riegger GA, Hamer OW, and Jeron A
- Subjects
- Adult, Aged, Equipment Design, Equipment Failure Analysis, Female, Humans, Male, Middle Aged, Radio Waves, Atrial Fibrillation surgery, Catheter Ablation instrumentation, Heart Conduction System surgery, Pulmonary Veins surgery, Transducers
- Abstract
Background: Ablation of atrial fibrillation (AF) has been one of the most difficult and time-consuming electrophysiological procedures. Due to the rapidly increasing demand for ablation procedures, technical advances would be helpful to reduce complexity and procedure time in AF ablation. Therefore, we investigated the feasibility of a single-catheter technique for pulmonary vein (PV) isolation utilizing a decapolar catheter combined with a duty-cycled, unipolar-bipolar radiofrequency (RF) generator., Methods: AF mapping and ablation was performed in 21 consecutive patients (mean age 59 +/- 12 years, 9 males) with paroxysmal AF (n = 17) and persistent AF (n = 4). The ablation catheter was forwarded to the LA via single-transseptal puncture. All electrodes were energized in 2 to 5 applications per vein, followed by segmental RF applications, as needed, to achieve electrical isolation. To assess left atrial anatomy for purposes of catheter manipulation, and later evaluate the possibility of asymptomatic PV-stenosis, CT or MR imaging was performed both prior to ablation and at 6-month follow-up., Results: Isolation could be achieved in 85/86 veins (99%). Procedure time for ablation was 81 +/- 13 minutes, and fluoroscopy time was 30 +/- 11 minutes. There were no procedural complications. Success rate at 6 months was 86% (18/21). MR or CT imaging excluded asymptomatic PV-stenosis., Conclusion: Mapping and ablation of PVs can be performed in a safe and efficient manner using a single-catheter technique, with short procedure times and minimal learning curve. Thus, this system may be of high interest not only for high volume but all centers performing AF ablation.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.